Surviving the Squeeze
October 26, 2026
The 2026 Power List discuss strategies for navigating today’s funding landscape in cell and gene therapy
4 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
Bruce Levine
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine
View ProfileMusings from The Power List: Claudia Zylberberg
Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale
Latest News
All the latest Medicine Maker articles.
Choosing a Sterile Fill-Finish Partner
October 22, 2026
Alcami’s Kerrie Powell, Senior VP of Sales, discusses the challenges of sterile biologics manufacturing and what sponsors should look for in a CDMO partner
5 min read
Meeting the Demands of Injectable Drug Delivery
October 22, 2026
Stevanato Group’s Adam Stops discusses how delivery systems and manufacturing capabilities can keep pace with increasingly complex drug formulations
1 min read
CAR NK Cells Target Cancer and Autoimmunity
October 21, 2026
mRNA nanoparticles reprogram NK cells in vivo, inducing tumor remissions and reducing autoimmune liver damage in mice.
2 min read
Prime Editing Corrects GATA2 Deficiency in Patient Stem Cells
October 21, 2026
The double-strand break-free approach increased functional GATA2 alleles and improved the engraftment of edited blood stem cells in mice
2 min read
Analytical Champions: Robert Wethman
October 21, 2026
Bristol Myers Squibb’s Robert Wethman discusses real-time spectroscopy, AI, and the next era of biopharmaceutical manufacturing
6 min read
How Genomics Is Personalizing Drug Discovery
October 20, 2026
Regeneron Genetics Center’s Luca Lotta explains how population-scale genetic evidence can reveal more promising drug targets and open new possibilities for disease prevention
4 min read
Musings from The Power List: Piers Ingram
October 20, 2026
Piers Ingram discusses the resurgence of immunology, engineering-led drug discovery, and how artificial intelligence can shape the next generation of medicines
4 min read
Gene Therapy Approach Shows Promise for Hydrocephalus
October 20, 2026
Researchers develop AAV-based method to target cerebrospinal fluid production, revealing new insights into postnatal neurogenesis
2 min read
Inside Kindeva’s New Sterile Fill-Finish Facility
October 20, 2026
John Wichelt discusses Kindeva’s Bridgeton facility, supporting injectable programs from clinical development through commercial manufacturing, and choosing a long-term fill-finish partner
5 min read
Making Clinical Trial Labels More Accessible
October 19, 2026
Thoughtful label design and digital tools can help participants with dyslexia find and access essential clinical trial information
5 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.